What is the price target for OPCH stock?
18 analysts have analysed OPCH and the average price target is 40.9 USD. This implies a price increase of 48.9% is expected in the next year compared to the current price of 27.47.
OPTION CARE HEALTH INC (OPCH) Forecast, Price Target & Analyst Ratings
NASDAQ:OPCH • US68404L2016
Current stock price
27.47 USD
+0.98 (+3.7%)
At close:
27.0433 USD
-0.43 (-1.55%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for OPTION CARE HEALTH INC (OPCH).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Apr 29, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.39
- Revenue Estimate
- 1.425B
Price Target Details & History
Consensus Price Target and Range
Mean target
$40.90
Upside
+ 48.90%
From current price of $27.47 to mean target of $40.90, Based on 18 analyst forecasts
Low
$37.37
Median
$40.80
High
$47.25
Price Target Revisions
1 Month
0.71%
3 Months
10.83%
Price Target Summary
18 Wall Street analysts provided a forecast for the next 12 months for OPCH. The average price target is 40.9 USD. This implies a price increase of 48.9% is expected in the next year compared to the current price of 27.47.
The average price target has been revised upward by 10.83% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
85.56%
OPCH was analyzed by 18 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about OPCH.
In the previous month the buy percentage consensus was at a similar level.
OPCH was analyzed by 18 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-16 | Barrington Research | Maintains | Outperform -> Outperform |
| 2026-01-13 | Citizens | Reiterate | Market Outperform -> Market Outperform |
| 2026-01-13 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-12-11 | Stephens & Co. | Initiate | Overweight |
| 2025-12-09 | Deutsche Bank | Maintains | Buy -> Buy |
| 2025-12-09 | B of A Securities | Maintains | Buy -> Buy |
| 2025-11-03 | TD Cowen | Maintains | Hold -> Hold |
| 2025-10-31 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-10-31 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-10-17 | Morgan Stanley | Initiate | Overweight |
| 2025-10-02 | TD Cowen | Initiate | Hold |
| 2025-09-23 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-07-31 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-07-10 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-06-18 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-04-30 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-04-30 | UBS | Upgrade | Neutral -> Buy |
| 2025-04-22 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-04-21 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-03-06 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-02-27 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-01-24 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-01-23 | Jefferies | Upgrade | Hold -> Buy |
| 2025-01-14 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-01-10 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 29, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.39
- Revenue Estimate
- 1.425B
- Revenue Q2Q
- 6.90%
- EPS Q2Q
- 37.77%
- Number of Analysts
- 14
Next Earnings Revisions
Revenue (1 Month)
-1.38%
Revenue (3 Months)
-2.26%
EPS (1 Month)
-5.46%
EPS (3 Months)
-8.26%
Next Earnings Summary
OPCH is expected to report earnings on 4/29/2026. The consensus EPS estimate for the next earnings is 0.39 USD and the consensus revenue estimate is 1.43B USD.
The next earnings revenue estimate has been revised downward by 2.26% in the past 3 months.
Full Analyst Estimates 2026 - 2030
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.302B 9.07% | 4.998B 16.17% | 5.65B 13.03% | 6.057B 7.21% | 6.575B 8.55% | 7.16B 8.90% | 7.817B 9.18% | 8.497B 8.70% | |
| EBITDA YoY % growth | 376.795M 23.30% | 385.331M 2.27% | 408.596M 6.04% | 504.94M 23.58% | 558.01M 10.51% | 618.7M 10.88% | 673.82M 8.91% | 739.04M 9.68% | |
| EBIT YoY % growth | 314.595M 30.97% | 321.833M 2.30% | 337.906M 4.99% | 393.84M 16.55% | 443.08M 12.50% | 495.47M 11.82% | 535.05M 7.99% | 593.87M 10.99% | |
| Operating Margin | 7.31% | 6.44% | 5.98% | 6.50% | 6.74% | 6.92% | 6.84% | 6.99% | |
| EPS YoY % growth | 1.47 86.08% | 1.22 -17.01% | 1.60 31.15% | 1.91 19.21% | 2.17 14.00% | 2.41 10.78% | 2.63 9.24% | 2.91 10.47% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.39 37.77% | 0.47 13.76% | 0.50 11.69% | 0.55 18.73% | 0.46 18.23% | 0.53 13.41% | 0.57 13.07% | 0.62 13.12% | 0.44 -3.09% | 0.52 -1.01% | 0.57 -0.08% | 0.64 4.01% |
| Revenue Q2Q % growth | 1.425B 6.90% | 1.516B 7.06% | 1.539B 7.25% | 1.579B 7.82% | 1.546B 8.49% | 1.645B 8.51% | 1.67B 8.51% | 1.715B 8.61% | 1.685B 8.99% | 1.788B 8.69% | 1.82B 8.98% | 1.872B 9.15% |
| EBITDA Q2Q % growth | 106.48M 11.43% | 124.64M 7.41% | 130.68M -3.11% | 142.23M -12.31% | 119.71M 12.42% | 136.61M 9.60% | 143.22M 9.60% | 157.23M 10.55% | 132.36M 10.57% | 149.63M 9.53% | 159.45M 11.33% | 178.34M 13.43% |
| EBIT Q2Q % growth | 81.225M 2.57% | 97.683M 18.10% | 103.31M 22.25% | 113.42M 23.95% | 94.894M 16.83% | 109.73M 12.33% | 116.03M 12.31% | 129.12M 13.84% | 107.58M 13.37% | 123.05M 12.14% | 132.48M 14.18% | 150.51M 16.57% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
14.61%
EPS Next 5 Year
12.68%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
7.57%
Revenue Next 5 Year
8.09%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
18.25%
EBIT Next 5 Year
14.58%
OPTION CARE HEALTH INC / OPCH Forecast FAQ
When does OPTION CARE HEALTH INC (OPCH) report earnings?
OPTION CARE HEALTH INC (OPCH) will report earnings on 2026-04-29.
What are the consensus estimates for OPCH stock next earnings?
The consensus EPS estimate for the next earnings of OPTION CARE HEALTH INC (OPCH) is 0.39 USD and the consensus revenue estimate is 1.43B USD.
How do analysts rate OPTION CARE HEALTH INC (OPCH)?
The consensus rating for OPTION CARE HEALTH INC (OPCH) is 85.5556 / 100 . This indicates that analysts generally have a positive outlook on the stock.